HomeTagsBiocytogen

Biocytogen

Biotechnology

Biocytogen Signs RenMab/RenLite Licensing Agreement with BeiGene

PR Newswire - April 27, 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") reached an agreement with BeiGene (Beijing) Co., Ltd. for licensing Biocytogen's fully human antibody RenMab/RenLite mice platforms to...

Biotechnology

Biocytogen/Eucure Biopharma Announce the Completion of First Patient Dosing for Phase II Clinical Trial of YH003 in Australia

PR Newswire - December 14, 2021

Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase II clinical trial of YH003 (anti-CD40 monoclonal antibody,...